Acasti Pharma (NASDAQ:ACST) Releases Earnings Results

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Up 6.5 % Shares of NASDAQ ACST opened at $2.61 on Tuesday. The firm has a market cap […]

Related Keywords

Canada ,Acasti Pharma ,Craig Hallum ,Acasti Pharma Company Profile ,Securities Exchange Commission ,Renaissance Technologies ,Acasti Pharma Inc ,Nasdaq ,Get Free Report ,Marketwatch Earnings ,Free Report ,Pharma Inc ,Acasti Pharma Daily ,Nasdaq Acst ,Pacst ,Medical ,Earnings ,